ICP DAS – BMP is a medical-grade TPU (thermoplastic polyurethane) manufacturer focused on supplying top-quality materials that prioritise “safety” and “quality.”
The company entered the industry in 2018 with success stories, earning the trust and confidence of over 100 worldwide medical device manufacturers shortly after its establishment. The competitive service offering includes providing a diverse range of 80 products and small order quantities with short delivery times.
ICP DAS – BMP produces three product series, including Alithane (ALP series), Durathane (ALC series), and Arothane (ARP series). The full range of medical-grade TPUs provides custom colour services, different hardnesses, and varying percentages of radiopaque fillers (Tungsten/Barium Sulfate) to suit customer-specific needs. Furthermore, the team performs rigorous quality inspections for each batch of TPU produced to guarantee the lot-to-lot consistency of medical-grade TPU pellets.
Peter Chen, the vice general manager of ICP DAS – BMP, has a strong background in chemical engineering and previously held a managerial position in the Polymer Division of ITRI – a world-renowned technology R&D institution in Taiwan. He brings substantial technical expertise to the BMP team and leads the R&D department to develop medical-grade TPUs.
A smart factory with IIoT systems further sharpens the ICP DAS – BMP competitive edge. By leveraging the 30-year automation expertise and resources of ICP DAS, the parent company of ICP DAS – BMP, the BMP team is empowered to monitor the machine status and environmental factors to optimise production efficiency and ensure consistent and high-quality products.
To fulfil the increasing TPU orders placed by clients, the imminent commissioning of the fourth production line will expand the existing production capacity and reduce lead times for better delivery reliability. Expert team, thorough testing, superior properties, short lead times, ICP DAS – BMP is poised to stand out in this field globally.